Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway
Background and Purpose. Metformin, a widely used antidiabetic drug, has been shown to have anti-inflammatory properties; nevertheless, its influence on β-cell meta-inflammation remains unclear. The following study investigated the effects of metformin on meta-inflammatory in β-cells and whether the...
Saved in:
Main Authors: | Ximei Shen, Beibei Fan, Xin Hu, Liufen Luo, Yuanli Yan, Liyong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2019/7602427 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipotoxicity and metabolic disorders at obesity
by: V. T. Ivashkin, et al.
Published: (2010-02-01) -
Role of the Btk-PLCγ2 Signaling Pathway in the Bone Destruction of Apical Periodontitis
by: Lina Wang, et al.
Published: (2019-01-01) -
Metformin versus insulin in glycemic control in pregnancy (MevIP): a randomized clinical trial protocol
by: Carolina Freitas Alves Amaral-Moreira, et al.
Published: (2025-02-01) -
Component-Based Formal Modeling of PLC Systems
by: Rui Wang, et al.
Published: (2013-01-01) -
β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
by: Kristoffer L. Egerod, et al.
Published: (2011-01-01)